This is a DNAse1L3 news story, published by MSN, that relates primarily to Lupus news.
For more DNAse1L3 news, you can click here:
more DNAse1L3 newsFor more Lupus news, you can click here:
more Lupus newsFor more disease research news, you can click here:
more disease research newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
genetic lupus. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest DNASE1L3 biologic news, DNAse1L3 replacement therapy news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
halting lupus developmentMedical Xpress - medical research advances and health news
•89% Informative
An enzyme-based treatment mitigated autoimmunity and reduced death rates in mouse lupus models.
The findings represent a significant advancement in autoimmune disease therapeutics.
Lupus is a chronic autoimmune disease that can cause inflammation and pain in any part of the body.
An estimated 35,000 patients with a pathogenic variant of DNAse1L3 that reduces the enzyme's activity.
VR Score
94
Informative language
97
Neutral language
66
Article tone
formal
Language
English
Language complexity
65
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
4
Source diversity
4
Affiliate links
no affiliate links